Article Versions Notes

Checa-Ros A, Okojie OJ, Wassouf JG, Yedean A, Hsueh W-C, Hebda P, Llobell ER, Muhmenthaler GB, Tran MD-D, D’Marco L. Glucagon-like Peptide Receptor Agonists and Kidney Outcomes in the Era of Personalized Medicine: Focus on Albuminuria. Journal of Personalized Medicine. 2026; 16(2):97. https://doi.org/10.3390/jpm16020097

Checa-Ros, Ana, Owahabanun Joshua Okojie, Jacob Gabriel Wassouf, Aida Yedean, Wei-Chung Hsueh, Patryk Hebda, Esther Rodriguez Llobell, Greta Bianca Muhmenthaler, Martin Duc-Duy Tran, and Luis D’Marco. 2026. "Glucagon-like Peptide Receptor Agonists and Kidney Outcomes in the Era of Personalized Medicine: Focus on Albuminuria" Journal of Personalized Medicine 16, no. 2: 97. https://doi.org/10.3390/jpm16020097

Checa-Ros, A., Okojie, O. J., Wassouf, J. G., Yedean, A., Hsueh, W.-C., Hebda, P., Llobell, E. R., Muhmenthaler, G. B., Tran, M. D.-D., & D’Marco, L. (2026). Glucagon-like Peptide Receptor Agonists and Kidney Outcomes in the Era of Personalized Medicine: Focus on Albuminuria. Journal of Personalized Medicine, 16(2), 97. https://doi.org/10.3390/jpm16020097